Zisook S, Ricketts J E
University of California, San Diego, La Jolla 92093.
Hillside J Clin Psychiatry. 1988;10(1):55-70.
Five case examples are presented to illustrate the role of psychopharmacology in the treatment of patients diagnosed as Borderline Personality Disorders. The cases range from organic through affective and schizophrenic syndromes which are not infrequently at the "border" of personality disorders, and which often respond to specific pharmacologic interventions. The importance of looking for and recognizing drug treatable syndromes within the wide array of patients who satisfy DSM-III criteria for Borderline Disorders is discussed.
本文列举了五个病例,以说明心理药理学在治疗被诊断为边缘型人格障碍患者中的作用。这些病例涵盖了器质性、情感性和精神分裂症综合征,这些综合征在人格障碍的“边缘”并不罕见,并且通常对特定的药物干预有反应。文中讨论了在满足《精神疾病诊断与统计手册》第三版(DSM-III)边缘型障碍标准的众多患者中寻找和识别可药物治疗综合征的重要性。